---
title: "European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280500121.md"
description: "European equities traded in the US saw a rise in American depositary receipts, increasing 1.39% to 1,731.11 on the S&P Europe Select ADR Index. Notable gainers included DBV Technologies (4.5%) and Evaxion (3.2%), while decliners were led by Natuzzi (-6.3%) and EDAP TMS (-4.7%). UK gainers included Biodexa Pharmaceuticals (6%) and Silence Therapeutics (5%), with NuCana (-1.9%) and Pearson (-0.7%) as the only decliners from the UK and Ireland."
datetime: "2026-03-25T15:16:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280500121.md)
  - [en](https://longbridge.com/en/news/280500121.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280500121.md)
---

# European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading

11:16 AM EDT, 03/25/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 1.39% to 1,731.11 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies ( DBVT ) and biotech firm Evaxion ( EVAX ) , which rose 4.5% and 3.2% respectively. They were followed by pharmaceutical company Ascendis Pharma ( ASND ) and biopharmaceutical company Grifols (GRFS), which were up 2.8% and 2.2% respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and medical device maker EDAP TMS ( EDAP ) , which fell 6.3% and 4.7% respectively. They were followed by internet browser company Opera (OPRA) and internet advertising firm Criteo ( CRTO ) , which were down 2.6% and 1% respectively.

The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and pharmaceutical company Silence Therapeutics ( SLN ) , which advanced 6% and 5% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and biotech firm Trinity Biotech ( TRIB ) , which increased 4.4% and 3.3% respectively.

The only decliners from the UK and Ireland were biopharmaceutical company NuCana ( NCNA ) and educational publisher Pearson (PSO), which dropped 1.9% and 0.7% respectively.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [DBVT.US](https://longbridge.com/en/quote/DBVT.US.md)
- [NCNA.US](https://longbridge.com/en/quote/NCNA.US.md)
- [FDD.US](https://longbridge.com/en/quote/FDD.US.md)
- [NTZ.US](https://longbridge.com/en/quote/NTZ.US.md)
- [EVAX.US](https://longbridge.com/en/quote/EVAX.US.md)
- [SPEU.US](https://longbridge.com/en/quote/SPEU.US.md)
- [BDRX.US](https://longbridge.com/en/quote/BDRX.US.md)
- [PSON.UK](https://longbridge.com/en/quote/PSON.UK.md)
- [EDAP.US](https://longbridge.com/en/quote/EDAP.US.md)
- [PSO.US](https://longbridge.com/en/quote/PSO.US.md)
- [SLN.US](https://longbridge.com/en/quote/SLN.US.md)

## Related News & Research

- [ADVISORY-Dated alerts on Pearson partnership with Salesforce withdrawn](https://longbridge.com/en/news/286117283.md)
- [New Pearson data shows students build proficiency with AI-powered practice | PSO Stock News](https://longbridge.com/en/news/285211911.md)
- [DBV Technologies says JPMorgan Chase beneficial stake rises to 11.49%](https://longbridge.com/en/news/287230466.md)
- [Pearson, PLC (NYSE:PSO) Receives Consensus Rating of "Moderate Buy" from Brokerages](https://longbridge.com/en/news/285689931.md)
- [Evaxion A/S Wins Shareholder Approval for Expanded Equity and Convertible Financing Powers](https://longbridge.com/en/news/283662971.md)